Related references
Note: Only part of the references are listed.Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials
Diyu Cui et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2021)
The Effect of Sacubitril-Valsartan in Heart Failure Patients With Mid-Range and Preserved Ejection Fraction: A Meta-Analysis
Dan Nie et al.
HEART LUNG AND CIRCULATION (2021)
Association between atrial fibrillation and heart failure with different ejection fraction categories and its influence on outcomes
Hai-Xia Xu et al.
ACTA CARDIOLOGICA (2020)
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis
Matthew W. Segar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Spironolactone use is associated with improved outcomes in heart failure with mid-range ejection fraction
Nobuyuki Enzan et al.
ESC HEART FAILURE (2020)
Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials
Kris Kumar et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Atrial fibrillation is associated with impaired exercise capacity and adverse prognosis in patients with heart failure with mid-range ejection fraction
Yu Sato et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Recovered Left Ventricular Ejection Fraction and Its Prognostic Impacts in Hospitalized Heart Failure Patients with Reduced Ejection Fraction
Satoshi Abe et al.
INTERNATIONAL HEART JOURNAL (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes
Jin Joo Park et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
Justin A. Ezekowitz et al.
JACC-HEART FAILURE (2020)
Heart Failure With Mid-range Ejection Fraction
Pratyaksh K. Srivastava et al.
CURRENT HEART FAILURE REPORTS (2020)
Outcomes of spironolactone treatment in patients in Northeast China suffering from heart failure with mid-range ejection fraction
Yan-guo Xin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Jun Hwan Cho et al.
CIRCULATION JOURNAL (2019)
Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction A meta-analysis of randomized clinical trials
Yajie Xiang et al.
MEDICINE (2019)
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction
Nicola Riccardo Pugliese et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2019)
The continuous heart failure spectrum: moving beyond an ejection fraction classification
Filippos Triposkiadis et al.
EUROPEAN HEART JOURNAL (2019)
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure
Gianluigi Savarese et al.
JACC-HEART FAILURE (2019)
Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®
Nasrien E. Ibrahim et al.
ESC HEART FAILURE (2019)
A Prospective, Multicenter, Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Tolvaptan in Patients with Reduced, Preserved, and Mid-Range Ejection Fraction Heart Failure
Koichiro Kinugawa et al.
INTERNATIONAL HEART JOURNAL (2019)
Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction
Jin Joo Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
Giuseppe Vergaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction The CHECK-HF Registry
Hans-Peter Brunner-La Rocca et al.
JACC-HEART FAILURE (2019)
Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study
Fernando Montenegro Sa et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2019)
The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
Yanguo Xin et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2019)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2018)
Predictors and outcomes of heart failure with mid-range ejection fraction
Vijeta Bhambhani et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction
Azmil H. Abdul-Rahim et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Characteristics and outcome for heart failure patients with mid-range ejection fraction
Nelson Wang et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2018)
Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function
Isabelle Johansson et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry
Barak Zafrir et al.
EUROPEAN HEART JOURNAL (2018)
The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis
Saif Altaie et al.
ESC HEART FAILURE (2018)
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome
Dimitrios Farmakis et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction
Ashish Rastogi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
A comprehensive population-based characterization of heart failure with mid-range ejection fraction
Angela S. Koh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction
Aisha Gohar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
Peter Rickenbacher et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study
Kanako Tsuji et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
V. Katsi et al.
HEART FAILURE REVIEWS (2017)
A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography
Patrick Collier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Heart Failure With Mid-Range (Borderline) Ejection Fraction Clinical Implications and Future Directions
Jeffrey J. Hsu et al.
JACC-HEART FAILURE (2017)
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
Jasper Tromp et al.
JACC-HEART FAILURE (2017)
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Ulrik Sartipy et al.
JACC-HEART FAILURE (2017)
Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization
Jonathan Buggey et al.
ESC HEART FAILURE (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Impact of Physical Inactivity on Mortality in Patients With Heart Failure
Rami Doukky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction
Andreas P. Kalogeropoulos et al.
JAMA CARDIOLOGY (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%)
Carolyn S. P. Lam et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction
Elisabeth Kraigher-Krainer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure
Gary L. Murray et al.
HEART INTERNATIONAL (2014)
Echocardiographic Evaluation of Left Ventricular Structure and Function: New Modalities and Potential Applications in Clinical Trials
Andreas P. Kalogeropoulos et al.
JOURNAL OF CARDIAC FAILURE (2012)
A Meta-analysis of the effects of Exercise Training on Left Ventricular Remodeling Following Myocardial Infarction: Start early and go longer for greatest exercise benefits on remodeling
Mark Haykowsky et al.
TRIALS (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials
Justin A. Ezekowitz et al.
EUROPEAN HEART JOURNAL (2009)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients - The benefit depends on the type of training performed
Mark J. Haykowsky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
L. Belardinelli et al.
HEART (2006)
Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography - A comparison with magnetic resonance imaging
S Malm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Share Paper
